Regeneron Pharmaceuticals, Inc.
Competitive Ligand Binding Assays

Last updated:

Abstract:

Improved assays for the detection and optionally the quantification of anti-drug antibodies (ADAs) in a sample are provided. The disclosed assays include a protein drug capture assay format and a protein drug target capture assay format, each of which have certain advantages over existing assays.

Status:
Application
Type:

Utility

Filling date:

12 May 2020

Issue date:

19 Nov 2020